Evidence map›Paper›PMID 36759126›Full record

ArticleRNA (New York, N.Y.)2023

m6A-ELISA, a simple method for quantifying

Imke Ensinck, Theodora Sideri, Miha Modic, Charlotte Capitanchik, Claudia Vivori, Patrick Toolan-Kerr, Folkert J van Werven

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Virtual screening and experimental validation of a METTL3-targeting peptide withJournal of enzyme inhibition and medicinal chemistry · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Targeting intracellular mRNA mJournal of advanced research · 2026
    Review
  7. Review
  8. Single-base mJournal of virology · 2025
    Article
  9. Impact of NbioRxiv : the preprint server for biology · 2025
    Article
  10. WTAP-mediated mScience China. Life sciences · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Diverse plant RNAs coatProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. When animal viruses meet NVeterinary research · 2024
    Review
  16. Article
  17. Article
  18. Antiretroviral Therapy Suppresses RNAAIDS research and human retroviruses · 2024
    Article
  19. Review
  20. Current progress in strategies to profile transcriptomic mFrontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Imke EnsinckThe Francis Crick Institute, London NW1 1AT, United Kingdom.ORCID 0000-0001-8468-9199
Theodora SideriThe Francis Crick Institute, London NW1 1AT, United Kingdom.ORCID 0000-0002-5674-0804
Miha ModicThe Francis Crick Institute, London NW1 1AT, United Kingdom.ORCID 0000-0002-2894-7218
Charlotte CapitanchikThe Francis Crick Institute, London NW1 1AT, United Kingdom.ORCID 0000-0001-9590-2792
Claudia VivoriThe Francis Crick Institute, London NW1 1AT, United Kingdom.ORCID 0000-0001-7008-0593
Patrick Toolan-KerrThe Francis Crick Institute, London NW1 1AT, United Kingdom.ORCID 0000-0002-7970-649X
Folkert J van WervenThe Francis Crick Institute, London NW1 1AT, United Kingdom folkert.vanwerven@crick.ac.uk.ORCID 0000-0002-6685-2084

Funding

Cancer Research UKMedical Research CouncilWellcome Trust FC001203
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntibodiesRNAAnimalsEnzyme-Linked Immunosorbent AssayMiceRNA, MessengerAntibodiesRNARNA, MessengerELISAm6AmESCyeast

Identifiers

PMID36759126
PMCPMC10159001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.